OmniActive appoints industry veteran Jim Hamilton as CEO EP News Bureau May 12, 2020 Sanjaya Mariwala has taken over as Executive Chairman
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir EP News Bureau May 12, 2020 Over 10 leading government and private hospitals in India are being enrolled for the study, Glenmark estimates study completion by…
Merck Granted US Patents for Foundational CRISPR-Cas9 Technology EP News Bureau May 12, 2020 CRISPR technology is a core competency for Merck, which has 16 years’ experience with genome editing, spanning discovery to…
Glenmark launches triple therapy inhaler EP News Bureau May 12, 2020 AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population
Hamdard Laboratories launches digital campaign about Covid-19 preventive measures EP News Bureau May 11, 2020 Its campaign #MainDarpokHoon features Phogat sisters, Rifle Daadis
Optima sets up centralised digital innovation centre EP News Bureau May 11, 2020 The center provides a firsthand experience of digital products and is available for all of its divisions
Demand for immunity products to be sustained long-term: SIRIO EP News Bureau May 11, 2020 Consumers are also purchasing products that strengthen their respiratory and cardiovascular systems, with Omega-3 fatty acids and…
‘Essential’ pharmaceuticals amid disrupted supply chains- A legal nightmare! EP News Bureau May 11, 2020 Can COVID-19 and the lockdown qualify as a force majeure event even when the pharmaceutical industry was never under a lockdown?…
FICCI launches first international ‘Virtual Healthcare and Hygiene Expo 2020’ EP News Bureau May 11, 2020 Global industry players to participate at India’s first virtual expo from 22-26 June 2020 Buyers from 120 countries will…
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics,… EP News Bureau May 11, 2020 The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options,…